Loading viewer...
earnings
Format: PDF earnings
Johnson & Johnson's second quarter 2023 earnings presentation delivered on July 20, 2023, outlining operational and financial performance across the company's pharmaceutical, medical devices, and consumer health segments. The presentation includes forward-looking statements regarding strategic initiatives, including the anticipated separation of the Consumer Health business into a standalone publicly traded company. Financial results, product development updates, and market positioning are discussed alongside risks and uncertainties affecting future performance.
earnings_deck
earnings
16 Pages
Ironwood Pharmaceuticals
Avista Corp Q4 2016 Earnings Webcast
earningsearnings
12 Pages
Avista Corporation
Ormat Technologies Q2 2023 Earnings Call
earningsearnings
34 Pages
Ormat Technologies